Literature DB >> 21418222

Crystallin-gazing: unveiling enzymatic activity.

Patrick W Reed, Robert J Bloch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21418222      PMCID： PMC9289992          DOI： 10.1111/j.1471-4159.2011.07249.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.546


× No keyword cloud information.
  11 in total

1.  Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.

Authors:  Daniel Martins-de-Souza; Giuseppina Maccarrone; Thomas Wobrock; Inga Zerr; Philipp Gormanns; Stefan Reckow; Peter Falkai; Andrea Schmitt; Christoph W Turck
Journal:  J Psychiatr Res       Date:  2010-05-14       Impact factor: 4.791

2.  Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein.

Authors:  M P Vié; C Evrard; J Osty; A Breton-Gilet; P Blanchet; M Pomérance; P Rouget; J Francon; J P Blondeau
Journal:  Mol Endocrinol       Date:  1997-10

3.  Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues.

Authors:  Satoko Abe; Toyomasa Katagiri; Akihiko Saito-Hisaminato; Shin-ichi Usami; Yasuhiro Inoue; Tatsuhiko Tsunoda; Yusuke Nakamura
Journal:  Am J Hum Genet       Date:  2002-12-06       Impact factor: 11.025

4.  Crystal structure of human micro-crystallin complexed with NADPH.

Authors:  Zhongjun Cheng; Lihua Sun; Jianhua He; Weimin Gong
Journal:  Protein Sci       Date:  2007-02       Impact factor: 6.725

5.  micro-Crystallin as an intracellular 3,5,3'-triiodothyronine holder in vivo.

Authors:  Satoru Suzuki; Nobuyoshi Suzuki; Jun-Ichirou Mori; Aki Oshima; Shinichi Usami; Kiyoshi Hashizume
Journal:  Mol Endocrinol       Date:  2007-01-30

6.  Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones.

Authors:  André Hallen; Arthur J L Cooper; Joanne F Jamie; Paul A Haynes; Robert D Willows
Journal:  J Neurochem       Date:  2011-03-15       Impact factor: 5.372

7.  CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.

Authors:  A Oshima; S Suzuki; Y Takumi; K Hashizume; S Abe; S Usami
Journal:  J Med Genet       Date:  2006-06       Impact factor: 6.318

8.  Nicotinamide adenine dinucleotide phosphate-dependent cytosolic T(3) binding protein as a regulator for T(3)-mediated transactivation.

Authors:  Jun-ichirou Mori; Satoru Suzuki; Mutsuhiro Kobayashi; Takeshi Inagaki; Ai Komatsu; Teiji Takeda; Takahide Miyamoto; Kazuo Ichikawa; Kiyoshi Hashizume
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

9.  Differential expression of presynaptic genes in a rat model of postnatal hypoxia: relevance to schizophrenia.

Authors:  J U Sommer; A Schmitt; M Heck; E L Schaeffer; M Fendt; M Zink; K Nieselt; S Symons; G Petroianu; A Lex; M Herrera-Marschitz; R Spanagel; P Falkai; P J Gebicke-Haerter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-14       Impact factor: 5.270

10.  Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy.

Authors:  Patrick W Reed; Andrea M Corse; Neil C Porter; Kevin M Flanigan; Robert J Bloch
Journal:  Exp Neurol       Date:  2007-03-21       Impact factor: 5.330
View more
  1 in total

1.  Identification and characterization of trans-3-hydroxy-l-proline dehydratase and Δ(1)-pyrroline-2-carboxylate reductase involved in trans-3-hydroxy-l-proline metabolism of bacteria.

Authors:  Seiya Watanabe; Yoshiaki Tanimoto; Seiji Yamauchi; Yuzuru Tozawa; Shigeki Sawayama; Yasuo Watanabe
Journal:  FEBS Open Bio       Date:  2014-02-26       Impact factor: 2.693
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.